Sign in

CIK 0001745999 · Large accelerated filer

Beam Therapeutics Inc.

Sign in to watch
Ticker
BEAM
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
857-327-8775
Business address
26 LANDSDOWNE STREET, CAMBRIDGE, MA, 02139
Former names
Beam Therapeutics Inc.
  1. 4 Grant or award SVP, Finance and Treasurer acquired 20,000 shares (grant or award)
  2. 4 Grant or award Chief Medical Officer acquired 31,750 shares (grant or award)
  3. 4 Grant or award Chief Financial Officer acquired 31,750 shares (grant or award)
  4. 4 Grant or award President acquired 40,000 shares (grant or award)
  5. 4 Planned sale CEO sold 50,000 shares at an average $22.57 ($1,128,315)
  6. 4 Planned sale President sold 35,000 shares at $32.00 ($1,120,042)
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Planned sale CEO sold 50,000 shares at an average $28.87 ($1,443,528)
  12. 4 Derivatives Options or other derivatives
  13. 4 Planned sale SVP, Finance and Treasurer sold 6,198 shares at $35.00 ($216,933)
  14. 4 Planned sale Chief Legal Officer sold 1,371 shares at $34.00 ($46,614)
  15. 4 Planned sale SVP, Finance and Treasurer sold 3,034 shares at $30.12 ($91,384)
  16. 4 Planned sale Chief Legal Officer sold 18,629 shares at an average $34.61 ($644,832)
  17. 4 Planned sale Chief Financial Officer sold 6,294 shares at $27.10 ($170,567)
  18. 4 Planned sale Chief Legal Officer sold 1,254 shares at $27.10 ($33,983)
  19. 4 Grant or award Chief Medical Officer acquired 12,500 shares (grant or award)
  20. 4 Open-market sale 10% owner sold 459 shares at $26.68 ($12,246)

Page 2 of 12 · 238 filings